ArticleMolecular imaging and radionuclide therapy2026
Bilateral Renal Metastases from Lung Adenocarcinoma Revealed on
Article in Molecular imaging and radionuclide therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer is the leading cause of cancer-related deaths worldwide. While metastasis to distant organs is commonly described, renal metastasis remains rare and uncommon. In this paper, we present the case of a 53-year-old man with a history of left apical lung adenocarcinoma who underwent fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (CT) for suspected recurrence. The scan revealed a recurrent pulmonary mass with metastatic spread, notably showing intense bilateral focal FDG uptake in the kidneys. A metastatic origin was suspected and subsequently confirmed by CT-guided renal biopsy. Although rare and typically observed in advanced stages of the disease, this case underscores the importance of carefully evaluating focal FDG uptake in the renal cortex to ensure accurate staging and optimal management of oncologic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.